Page last updated: 2024-10-27

fluoxetine and Bladder, Overactive

fluoxetine has been researched along with Bladder, Overactive in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Mizutani, H1
Sakakibara, F1
Sasaki, E1
Wróbel, A1
Serefko, A1
Poleszak, E1
Rechberger, T1

Other Studies

2 other studies available for fluoxetine and Bladder, Overactive

ArticleYear
TAS-303 Ameliorates Carbachol-Induced Detrusor Overactivity in Rats, Revealing Its Therapeutic Potential for Overactive Bladder.
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 374, Issue:1

    Topics: Adrenergic beta-3 Receptor Antagonists; Animals; Atropine; Carbachol; Dose-Response Relationship, Dr

2020
Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.
    International urogynecology journal, 2016, Volume: 27, Issue:11

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Corticosterone; Depression; Disease

2016